![](/img/cover-not-exists.png)
A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study
James V. Fiorica, John A. Blessing, Louis V. Puneky, Angeles Alvarez Secord, James S. Hoffman, S. Diane Yamada, Thomas E. Buekers, Jeffrey Bell, Jeanne M. SchilderVolume:
115
Year:
2009
Language:
english
Pages:
5
DOI:
10.1016/j.ygyno.2009.07.024
File:
PDF, 142 KB
english, 2009